Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Net Income (2020 - 2025)

Historic Net Income for BioScience Health Innovations (BHIC) over the last 6 years, with Q3 2025 value amounting to -$8782.0.

  • BioScience Health Innovations' Net Income fell 11562.58% to -$8782.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $885677.0, marking a year-over-year increase of 219052.42%. This contributed to the annual value of $87000.0 for FY2024, which is 13459.24% up from last year.
  • Per BioScience Health Innovations' latest filing, its Net Income stood at -$8782.0 for Q3 2025, which was down 11562.58% from $457704.0 recorded in Q2 2025.
  • BioScience Health Innovations' 5-year Net Income high stood at $457704.0 for Q2 2025, and its period low was -$85262.0 during Q2 2023.
  • For the 5-year period, BioScience Health Innovations' Net Income averaged around $30477.0, with its median value being -$12668.0 (2021).
  • In the last 5 years, BioScience Health Innovations' Net Income plummeted by 139217.82% in 2022 and then soared by 89953.17% in 2025.
  • BioScience Health Innovations' Net Income (Quarter) stood at -$14089.0 in 2021, then tumbled by 105.25% to -$28917.0 in 2022, then plummeted by 32.71% to -$38376.0 in 2023, then soared by 125.95% to $9957.0 in 2024, then plummeted by 188.2% to -$8782.0 in 2025.
  • Its Net Income stands at -$8782.0 for Q3 2025, versus $457704.0 for Q2 2025 and $426798.0 for Q1 2025.